Ezio Bonvini - May 14, 2022 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role
Sr VP, Research & CSO
Signature
/s/ Lynn Cilinski, Attorney-in-Fact
Stock symbol
MGNX
Transactions as of
May 14, 2022
Transactions value $
-$6,931
Form type
4
Date filed
5/17/2022, 05:28 PM
Previous filing
Feb 24, 2022
Next filing
Feb 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGNX Common Stock Options Exercise $0 +5K +4.5% $0.00 116K May 14, 2022 Direct F1
transaction MGNX Common Stock Tax liability -$6.93K -1.67K -1.44% $4.16 114K May 14, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGNX Restricted Stock Unit Options Exercise $0 -5K -100% $0.00* 0 May 14, 2022 Common Stock 5K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 14, 2020, the reporting person was granted 10,000 restricted stock units, 50% of which vested on May 14, 2021 and 50% of which vested on May 14, 2022. Restricted stock units convert into the Company's common stock on a one-for-one basis